Although CD90 is a typical marker of CSCs in HCC and high CD90 expression has been linked to higher recurrence rate38, 39, one study reported that CD90+ CSCs-like cells in the liver may participate only in late-stage liver cancer associated with hepatitis B virus infection40. This evidence concerns the gene THY1 and liver cancer.